Real-World Testing of an Artificial Intelligence Conversational Agent as an Early Intervention and Support Tool in the Mental Health Referral Care Pathway: A Mixed-Methods Study.

IF 2.7 4区 医学 Q2 PSYCHIATRY
Edward Meinert, Madison Milne-Ives, Emma Taylor, Becky Inkster, Alina Paik, Ananya Ananthakrishnan, Martin Orr, Ceire Costelloe, Rohit Shankar
{"title":"Real-World Testing of an Artificial Intelligence Conversational Agent as an Early Intervention and Support Tool in the Mental Health Referral Care Pathway: A Mixed-Methods Study.","authors":"Edward Meinert, Madison Milne-Ives, Emma Taylor, Becky Inkster, Alina Paik, Ananya Ananthakrishnan, Martin Orr, Ceire Costelloe, Rohit Shankar","doi":"10.1177/00207640251415507","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The incidence of mental health concerns is growing, and demand for support is exceeding service capacity. Digital tools can provide additional support but risk causing harm if not delivered safely.</p><p><strong>Aims: </strong>We aimed to establish real-world evidence of the impact of an artificial intelligence-based mental health conversational agent (Wysa) on depression and anxiety in patients waiting for Talking Therapies treatment.</p><p><strong>Methods: </strong>A mixed-methods randomized controlled trial was conducted with patients referred to Talking Therapies in the Central and Northwest London NHS Foundation Trust. The primary outcome was change in depression severity over 12 weeks between groups; secondary outcomes included anxiety severity, quality of life, safety, engagement, and app usage. Comparative analyses used linear regression; thematic analysis was conducted on qualitative data.</p><p><strong>Results: </strong>2,161 patients were screened, 625 were invited, 99 consented, and 76 were randomized (2:1). Thirty patients were lost to follow-up. Descriptive analysis found that mean differences in depression were similar between arms, but with large standard deviations (<i>M</i> = 2.62, <i>SD</i> = 5.07 and 6.56 for Wysa; <i>M</i> = 2.59, <i>SD</i> = 4.38 and 3.82 for control). Results were similar for secondary outcomes. Wysa was potentially helpful, easy to use, and appreciated as an accessible source of support, but limitations with the conversational agent negatively affected engagement.</p><p><strong>Conclusions: </strong>Although sample size limited the analysis, participant feedback highlighted its potential to supplement clinical services. Our study findings suggest that the change of depression score is similar in both arms thus indicating that there is no evidence that Wysa treats depression in this study. However, limited sample size could have influenced this. Key lessons to improve the quality of effectiveness studies of digital health technologies were identified.</p>","PeriodicalId":14304,"journal":{"name":"International Journal of Social Psychiatry","volume":" ","pages":"1819-1832"},"PeriodicalIF":2.7000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13569919/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Social Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00207640251415507","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/5 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The incidence of mental health concerns is growing, and demand for support is exceeding service capacity. Digital tools can provide additional support but risk causing harm if not delivered safely.

Aims: We aimed to establish real-world evidence of the impact of an artificial intelligence-based mental health conversational agent (Wysa) on depression and anxiety in patients waiting for Talking Therapies treatment.

Methods: A mixed-methods randomized controlled trial was conducted with patients referred to Talking Therapies in the Central and Northwest London NHS Foundation Trust. The primary outcome was change in depression severity over 12 weeks between groups; secondary outcomes included anxiety severity, quality of life, safety, engagement, and app usage. Comparative analyses used linear regression; thematic analysis was conducted on qualitative data.

Results: 2,161 patients were screened, 625 were invited, 99 consented, and 76 were randomized (2:1). Thirty patients were lost to follow-up. Descriptive analysis found that mean differences in depression were similar between arms, but with large standard deviations (M = 2.62, SD = 5.07 and 6.56 for Wysa; M = 2.59, SD = 4.38 and 3.82 for control). Results were similar for secondary outcomes. Wysa was potentially helpful, easy to use, and appreciated as an accessible source of support, but limitations with the conversational agent negatively affected engagement.

Conclusions: Although sample size limited the analysis, participant feedback highlighted its potential to supplement clinical services. Our study findings suggest that the change of depression score is similar in both arms thus indicating that there is no evidence that Wysa treats depression in this study. However, limited sample size could have influenced this. Key lessons to improve the quality of effectiveness studies of digital health technologies were identified.

人工智能会话代理在心理健康转诊护理途径中作为早期干预和支持工具的真实世界测试:一项混合方法研究
背景:心理健康问题的发生率正在上升,对支持的需求超出了服务能力。数字工具可以提供额外的支持,但如果不安全交付,可能会造成伤害。目的:我们旨在建立基于人工智能的心理健康会话代理(Wysa)对等待谈话疗法治疗的患者的抑郁和焦虑的影响的现实证据。方法:对伦敦中部和西北部NHS基金会信托的谈话疗法患者进行了一项混合方法随机对照试验。主要结局是各组间抑郁严重程度在12周内的变化;次要结果包括焦虑严重程度、生活质量、安全性、参与度和应用程序使用情况。比较分析采用线性回归;对定性数据进行专题分析。结果:筛选2161例患者,邀请625例,同意99例,随机76例(2:1)。30例患者未随访。描述性分析发现两组间抑郁的平均差异相似,但标准差较大(Wysa组M = 2.62, SD = 5.07和6.56;对照组M = 2.59, SD = 4.38和3.82)。次要结局的结果相似。Wysa有潜在的帮助,易于使用,并作为一个可访问的支持来源而受到赞赏,但会话代理的局限性对参与度产生了负面影响。结论:虽然样本量限制了分析,但参与者的反馈强调了其补充临床服务的潜力。我们的研究结果表明,两组患者抑郁评分的变化相似,因此没有证据表明Wysa在本研究中治疗抑郁症。然而,有限的样本量可能会影响这一点。确定了提高数字卫生技术有效性研究质量的关键经验教训。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
12.30
自引率
1.30%
发文量
120
期刊介绍: The International Journal of Social Psychiatry, established in 1954, is a leading publication dedicated to the field of social psychiatry. It serves as a platform for the exchange of research findings and discussions on the influence of social, environmental, and cultural factors on mental health and well-being. The journal is particularly relevant to psychiatrists and multidisciplinary professionals globally who are interested in understanding the broader context of psychiatric disorders and their impact on individuals and communities. Social psychiatry, as a discipline, focuses on the origins and outcomes of mental health issues within a social framework, recognizing the interplay between societal structures and individual mental health. The journal draws connections with related fields such as social anthropology, cultural psychiatry, and sociology, and is influenced by the latest developments in these areas. The journal also places a special emphasis on fast-track publication for brief communications, ensuring that timely and significant research can be disseminated quickly. Additionally, it strives to reflect its international readership by publishing state-of-the-art reviews from various regions around the world, showcasing the diverse practices and perspectives within the psychiatric disciplines. This approach not only contributes to the scientific understanding of social psychiatry but also supports the global exchange of knowledge and best practices in mental health care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书